Reaction Details Report a problem with these data
Target
Cytochrome P450 3A4
Ligand
BDBM50356587
Substrate
n/a
Meas. Tech.
ChEMBL_774850 (CHEMBL1913192)
IC50
>17000±n/a nM
Citation
 Wang, W; Devasthale, P; Wang, A; Harrity, T; Egan, D; Morgan, N; Cap, M; Fura, A; Klei, HE; Kish, K; Weigelt, C; Sun, L; Levesque, P; Li, YX; Zahler, R; Kirby, MS; Hamann, LG 7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site. Bioorg Med Chem Lett 21:6646-51 (2011) [PubMed]  Article 
Target
Name:
Cytochrome P450 3A4
Synonyms:
Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase
Type:
Enzyme
Mol. Mass.:
57349.57
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
503
Sequence:
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA
  
Inhibitor
Name:
BDBM50356587
Synonyms:
CHEMBL1910121
Type:
Small organic molecule
Emp. Form.:
C22H25Cl2N5O4S
Mol. Mass.:
526.436
SMILES:
Cc1nc2C(=O)N(CC(=O)N3CCN(CC3)S(C)(=O)=O)Cc2c(c1CN)-c1ccc(Cl)cc1Cl |(48.61,-29.07,;47.28,-29.84,;45.95,-29.08,;44.62,-29.86,;43.16,-29.38,;42.68,-27.91,;42.25,-30.62,;40.72,-30.62,;39.95,-31.96,;40.72,-33.29,;38.41,-31.96,;37.64,-30.63,;36.11,-30.63,;35.33,-31.96,;36.1,-33.29,;37.65,-33.3,;33.79,-31.95,;33.03,-30.62,;32.45,-32.72,;33.78,-33.49,;43.15,-31.87,;44.62,-31.4,;45.95,-32.17,;47.29,-31.39,;48.62,-32.16,;49.96,-31.39,;45.95,-33.7,;44.62,-34.47,;44.62,-36.01,;45.95,-36.78,;45.95,-38.32,;47.29,-36,;47.28,-34.47,;48.61,-33.69,)|
Structure:
Search PDB for entries with ligand similarity: